person

Emmanuel G.

Country
France
Department
Hematolgy

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
281
Sites with multiple studies

Has run more than one trial at 281 of 488 partner sites.

Specializations

Myelodysplastic Syndromes

Specializes in investigating novel therapeutic approaches for myelodysplastic syndromes across different risk categories, with particular focus on treatment options for both higher-risk and lower-risk MDS patients.

  • IDH1/IDH2 mutation targeted therapies
  • Erythropoiesis-stimulating agents
  • Novel combination therapies

Leads research into transfusion-dependent and transfusion-independent disease management strategies.

Lymphoma Research

Conducts comprehensive research in various lymphoma subtypes, including diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma.

  • B-cell lymphoma therapies
  • Novel antibody treatments
  • Combination immunotherapy approaches

Explores innovative treatment combinations targeting both newly diagnosed and relapsed/refractory disease states.

Acute Leukemia Studies

Focuses on advancing treatment options for acute myeloid leukemia and acute lymphoblastic leukemia, with emphasis on targeted therapies and novel drug combinations.

  • Age-specific treatment strategies
  • Mutation-targeted therapies
  • Innovative drug combinations

Investigates treatments across different age groups and genetic profiles.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.